METHVEN S, MACGREGOR MS, TRAYNOR JP, O'REILLY DS, DEIGHAN CJ NEPHROL DIAL TRANSPLANT, SEPT 2010 Assessing proteinuria in chronic kidney disease: protein–creatinine.

Slides:



Advertisements
Similar presentations
Chronic kidney disease
Advertisements

Chronic kidney disease
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
The PREVEND Study: Screening for micro-albuminuria
Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Ron T. Gansevoort Coordinator PREVEND Study Department of Nephrology University Medical Center Groningen The Netherlands Ron T. Gansevoort Coordinator.
Proteinuria as a Surrogate Outcome in Chronic Kidney Disease Early Diabetes – Microalbuminuria (MA) Type 2 Diabetes in American Indians Robert G Nelson,
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
Canadian Diabetes Association Clinical Practice Guidelines Chronic Kidney Disease in Diabetes Chapter 29 Phil McFarlane, Richard E. Gilbert, Lori MacCallum,
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States Ian H. de Boer, MD, MS, Tessa C. Rue, MS, Yoshio N. Hall, MD, Patrick.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.
Lesley Stevens MD Tufts-New England Medical Center
Kidney Function Tests Contents: Functional units Kidney functions Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Lecture 9.  Presence of excess of serum proteins in the urine is called proteinuria.  The excess of protein leads to foamy or frothy urine  Up to 150.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
Continuity Clinic Proteinuria. Continuity Clinic.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Estimated GFR Based on Creatinine and Cystatin C
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
RENAL DISEASE IN DIABETES
Diabetic Nephropathy Yiming Lit, M.D. May 5, 2009.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
New Concepts in Chronic Kidney Disease Jonathan B. Jaffery, MD Assistant Professor of Medicine University of Wisconsin-Madison.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.
These slides were sponsored by Janssen and developed in conjunction with the BRS CKD Strategy Group, following an advisory board that was organised by.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study) Lambers Heerspink,
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Kidney Function Tests. Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine.
Chronic Kidney Disease (CKD) Epidemiology A NEW EPIDEMIC: CHRONIC KIDNEY DISEASE IN GENERAL POPULATION REAL PREVALENCE AND RELATED FACTORS Josep M. Galceran,
Kidney Function Tests.
Proteinuria as a surrogate outcome in CKD UKPDS Rudy Bilous Middlesbrough, UK.
Dick de Zeeuw Department of Clinical Pharmacology University Medical Center Groningen The Netherlands Albuminuria; a tool for measuring non-blood pressure.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Kimberly Dunbar, PA-S2 Follow-up of Cardiovascular Risk Markers in Hypertensive Patients Treated with Irbesartan: Results of the i-SEARCH Plus Registry.
Renal damage occurs in 1 out of 4 hypertensives Adapted from Leoncini et al. J Hypertens. 2008;26:
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Clinical Decision on A Diagnostic Test. Clinical Question In a middle aged man with primary gout and azotemia, can a urine uric acid to creatinine ratio.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
Risk Involved with Dual RAAS Blockade in Kidney Disease Source: Bakris GL. Dual RAAS blockade is desirable in kidney disease: Con. Kidney Int. 2010;78:546–549.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Using Albumin:Creatinine Ratio (ACR) for Nephrology Referral in Primary Care Sohan Shah.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Sickle Cell Trait With Chronic Kidney.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
A Dipstick Protein and specific Gravity Algorithm Accurately Predicts Pathological Proteinuria Marigel Constantiner, RPh, MS, Ashwini R. Sehgal, MD, Lisa.
Section 2: Detection of CKD
The Significance of Albuminuria
Section 4: Managing progression of CKD
Lab (5): Renal Function test (RFT) (Part 2)
The MDRD Study.
Estimated GFR in Diabetes
So What is Albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction that symbolizes the kidney’s way to translate the.
Chapter 1: CKD in the General Population
Volume 79, Issue 12, Pages (June 2011)
Hypertension evaluation
Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Presentation transcript:

METHVEN S, MACGREGOR MS, TRAYNOR JP, O'REILLY DS, DEIGHAN CJ NEPHROL DIAL TRANSPLANT, SEPT 2010 Assessing proteinuria in chronic kidney disease: protein–creatinine ratio versus albumin–creatinine ratio SPEAKER : Dr. RAHUL CHAUDHARY SENIOR RESIDENT : Dr. ANURAG

Introduction Identification and quantification of proteinuria are core elements in the diagnosis and management of CKD Proteinuria is associated with  an increased risk of progressive kidney failure  cardiovascular disease and death  monitor the progress of kidney disease  to assess response to therapy Timed urine collections (usually performed over 24 h) are considered the gold standard

Urine formation

Urine proteins TOTAL PROTEIN = 150 – 200mg/day ; ALBUMIN <30mg/day

How to assess the amount of protein in urine? 24 – hour urine collection Poor compliance ; difficult in OPD set up Random urine protein/albumin concentration Variation in urine protein excretion (water intake,rate of diuresis,exercise,diet….) Urine protein creatinine ratio Protein and creatinine excretion rates are fairly constant throughout the day as long as the GFR remains constant

Introduction CONCLUSION :The protein : creatinine ratio on a random urine specimen provides evidence to “rule out” the presence of significant proteinuria as defined by a 24-h urine excretion measurement.

Guideline recommendations Guideline Recommendation KDOQI ( Kidney disease outcome quality initiative) Monitor proteinuria using ACR unless ACR exceeds mg/g, when TPCR is acceptable NICE (National institute for health and clinical excellence) ACR for urine analysis CARI ( Caring for Australasians with renal impairment) TPCR in patients with non-diabetic kidney disease ACR for diabetic patients

Aim of the study Examine the relationship between TPCR, ACR and 24-hr urinary protein Compare the diagnostic performance of TPCR and ACR at various thresholds To decide which is the optimal test to identify significant proteinuria

Materials and methods Single centre study  Kilmarnock, UK Retrospective analysis Perusal of records in the electronic patient record Laboratory assays  Random spot urine samples sent for all patients attending the renal clinic  24 hr urine evaluation done only on request AnalyserUrine albuminUrinary protein Prior to Aug 2006Bayer Advia 1650Immunoturbidimetry using anti-human albumin antiserum Pyrogallol red calorimetric method After Aug 2006Abbott Architect 2000 Immunoturbidimetry using anti-human albumin antiserum Turbidimetric method using benzethonium No significant difference in the precision and accuracy of two methods

Method of patient selection Searched for patients with TPCR and ACR measured on the same date 7830 patients were identified with simultaneous ACR and TPCR results Exclusions :  489 samples were analysed prior to 29 November 1999 and laboratory assay details were unavailable  88 children <18 years old excluded  411 patients receiving renal replacement therapy

Data acquisition Following details were recorded  Gender  Age at the time of urine collection  Primary renal disease  Use of ACE-I / ARB  Weight / height / Blood pressure  Serum creatinine  eGFR using the 4 variable MDRD equation Correlation was assessed using spearman’s rho Bland-Altman analysis was used to compare different measures of proteinuria Receiver operator curve were constructed to allow comparison of assays for key threshold values of proteinuria ACE-I – angi0tensin converting enzyme inhibitors;ARB –angiotensin receptor blockers;eGFR – estimated Glomerular filtration rate;MDRD – modification of diet in renal disease

Baseline characteristics

Relationship between ACR and TPCR Relationship was non-linear ACR is always less than TPCR (as expected)

TPCR, ACR and 24h urine protein  Results were available for 1696 patients  TPCR is more highly correlated with 24hr urine protein  In the range mg/day where clinical decisions are made, there is greater scatter with ACR

Ability of TPCR or ACR for prediction TPCR is more sensitive than ACR but less specific 24hr urine protein used as a gold standard

ROC curve analysis

Discussion LIMITATIONS Retrospective study Relationship demonstrated may only apply to the assay used in this study STRENGTH Large number of patients Representative nature of unselected adult population attending a general nephrology clinic.

Discussion TPCR is a highly sensitive and reasonable specific test for detection of significant proteinuria ie it can be used to rule out the presence of proteinuria and in those patients who have a positive result a full 24 hour collection and quantification is indicated. ACR performs significantly less well by ROC curve analysis Since these are screening tests, hence sensitivity is more important Total proteinuria cannot be predicted from albuminuria because of the variable proportion of non albumin proteins The diagnostic performances of both tests vary with age, gender, and to some extent eGFR, an effect that is related to muscle mass – hence clinician should interpret the result with the patient’s muscle mass in mind rather than rigidly sticking to a single cut off point.

Discussion Both ratios have their own limitations ─ TPCR and ACR may underestimate 24hour protein excretion ─ Analysis must be immediately done in a fresh sample ─ Urine creatinine measurement is another source of error ─ Urine creatinine is variable and hence the ratio is variable.

Figure 26.8 The Renal Corpuscle Figure 26.8a, b

Interpretation of Urine Albumin to Creatinine Ratio  Normal Ratio (in general <30 mg/g is normal)  Men: < (or 17 mg albumin to 1 gramCreatinine)Creatinine  Women: <0.025 (or 25 mg albumin to 1 gram Creatinine)Creatinine  Microalbuminuria: mg albumin/g CreatinineCreatinine  Macroalbuminuria: >300 mg albumin/g CreatinineCreatinine

Comparison of different measures of urinary protein excretion for prediction of renal events. Heerspink HJ, et al. J Am Soc Nephrol 21: 1355–1360,2010 Heerspink et al (2010) did a study on 701 participants of the Reduction In Endpoints in Non insulin Dependent Diabetes Mellitus with the Angiotensin-II Antagonist Losartan (RENAAL) trial Four standard methods for measuring urine protein compared:  24-hour urine protein excretion  24-hour urine albumin excretion  First morning void spot urine albumin conc  First morning void spot urine albumin-to-creatinine ratio (ACR)

Study addressed which of the four methods most strongly associates with the clinical outcome of renal progression, defined by a doubling of serum creatinine or the development of ESRD All four methods were strongly associated with renal progression Associations for Spot urine ACR were modestly stronger than those for the Other urine protein measurements and the superiority of urine ACR was consistent across subgroups defined by gender, race,and age